NCT00320060View on ClinicalTrials.gov

Effect of Pyridorin in Patients With Diabetic Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

January 31, 2003

Conditions
Diabetic Nephropathy
Interventions
DRUG

Pyridorin (pyridoxamine dihydrochloride)

Sponsors

Lead Sponsor

BioStratum
All Listed Sponsors
lead

BioStratum

INDUSTRY

NCT00320060 - Effect of Pyridorin in Patients With Diabetic Nephropathy | Biotech Hunter | Biotech Hunter